PubRank

Thad A Howard

Author PubWeight™ 18.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2003 2.55
2 Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 2013 1.52
3 Chemical and functional analysis of hydroxyurea oral solutions. J Pediatr Hematol Oncol 2004 1.30
4 Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res 2010 1.24
5 Genetic predictors for stroke in children with sickle cell anemia. Blood 2011 1.12
6 Quantitative analysis of Howell-Jolly bodies in children with sickle cell disease. Exp Hematol 2007 1.06
7 Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes. Am J Hematol 2013 1.06
8 Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure. Br J Haematol 2011 0.99
9 Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial. Pediatr Blood Cancer 2011 0.96
10 Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia. Blood 2011 0.86
11 UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med 2003 0.84
12 UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia. Am J Hematol 2008 0.84
13 Identification of hemochromatosis gene polymorphisms in chronically transfused patients with sickle cell disease. Am J Hematol 2003 0.84
14 Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia. Br J Haematol 2012 0.82
15 Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia/HbE. Pharmacology 2006 0.80
16 A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression. Am J Hematol 2011 0.79
17 Increased expression of anti-apoptosis genes in peripheral blood cells from patients with paroxysmal nocturnal hemoglobinuria. Mol Genet Metab 2003 0.76
18 A pharmacokinetic study of paracetamol in Thai beta-thalassemia/HbE patients. Eur J Clin Pharmacol 2006 0.75